DOOGAN DECLAN purchased 2330.7% of their position (53K shares) of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $101.8K — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+53K
Price / share
$1.92
Trade value
$101.76K
% of position
Net shares
+53K
Net value
$101.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2026 | P · Purchase | +53K | $1.92 | $101.76K | 2330.7% | 2.27K | 55.27K |
| Total | +53K | $101.76K | ||||||
Stock Option (right to buy)
DirectUnderlying shares
100K
Shares owned
100K
Exercise price
5.94
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
4.00
Shares owned
4.00
Exercise price
3200
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
4.00
Shares owned
4.00
Exercise price
992
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
80K
Shares owned
80K
Exercise price
5.75
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
30K
Shares owned
30K
Exercise price
13.30
Expiration
—
Exercise window
—
Underlying
210.01K
Owned
210.01K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 5.94 | — | — | 100K | 100K |
| Stock Option (right to buy) Direct | Common Stock | 3200 | — | — | 4.00 | 4.00 |
| Stock Option (right to buy) Direct | Common Stock | 992 | — | — | 4.00 | 4.00 |
| Stock Option (right to buy) Direct | Common Stock | 5.75 | — | — | 80K | 80K |
| Stock Option (right to buy) Direct | Common Stock | 13.30 | — | — | 30K | 30K |
| Total | 210.01K | 210.01K | ||||